98%
921
2 minutes
20
Background: Osteoporosis is a common complication in cardiac transplant recipients. While dual-energy X-ray absorptiometry (DEXA) is the standard method for assessing bone mineral density (BMD), it has limitations. This study aimed to evaluate the potential of using routine non-contrast chest CTs in cardiac transplant patients to assess BMD and vertebral body height.
Methods: 98 cardiac transplant patients who had undergone CTs before and after transplantation, along with DEXA scans, were included in this observational study. The CTs were used to measure vertebral bone density and height at thoracic vertebral levels. CT-based bone density before and after transplantation was compared and correlated with DEXA scan bone density.
Results: The findings revealed a significant decrease in vertebral bone density in the middle thoracic region (T5-T8) from 175 to 163 Hounsfield Units (HU) and in the lower thoracic region (T9-T12) from 163 to 146 HU after transplantation (P<.05). A strong correlation was observed between the bone density values derived from CTs and those from DEXA scans (P<.05). Furthermore, vertebral body height significantly changed at specific levels (T3, T6, T11, and T12) (P<.05). The anterior and middle portions of vertebral body showed a significant reduction in median height of 0.02 cm and 0.03 cm, respectively (P<.05), while changes in the posterior portion were not significant (P>.05).
Conclusion: Routine non-contrast chest CTs commonly performed for cardiac transplant patients, can effectively assess bone density, presenting a potential alternative to DEXA scans in this patient population.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.acra.2025.08.024 | DOI Listing |
Stem Cell Rev Rep
September 2025
Department of Medical Genetics and Prenatal Diagnostics, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
The emergence of organoid models has significantly bridged the gap between traditional cell cultures/animal models and authentic human disease states, particularly for genetic disorders, where their inherent genetic fidelity enables more biologically relevant research directions and enhances translational validity. This review systematically analyzes established organoid models of genetic diseases across organs (e.g.
View Article and Find Full Text PDFNat Commun
September 2025
Department of Biochemistry, University of Illinois, Urbana-Champaign, IL, USA.
Individuals with progressive liver failure risk dying without liver transplantation. However, our understanding of why regenerative responses are disrupted in failing livers is limited. Here, we perform multiomic profiling of healthy and diseased human livers using bulk and single-nucleus RNA- and ATAC-seq.
View Article and Find Full Text PDFPediatrics
September 2025
Department of Pediatrics, Section of Cardiology, Arkansas Children's Hospital, Little Rock, Arkansas.
Surgical innovation spans a spectrum from minor modifications of existing procedures to the development of new procedures. Surgeons routinely innovate at the lower end of this spectrum to adapt standardized procedures to the unique needs of individual patients. These innovations can be made at the surgeon's discretion without external oversight because they form part of clinical practice.
View Article and Find Full Text PDFPerfusion
September 2025
Cardiac Surgery Department, Bristol Royal Children's Hospital, Bristol, UK.
BackgroundDuring cardiopulmonary bypass (CPB), goal-directed perfusion (GDP) seeks to match oxygen delivery to metabolic demand, but the dynamics of oxygen extraction and intraoperative oxygen demand remain poorly understood, especially in paediatric populations. Existing models rely on limited data and assume, for example, a linear relationship between log oxygen demand and temperature.MethodsWe developed GARIX (Global AutoRegressive Integrated model with eXogenous variables and an equilibrium force) to predict minute-by-minute changes in oxygen extraction ratio (OER) using high-resolution intraoperative data.
View Article and Find Full Text PDFJ Thorac Cardiovasc Surg
September 2025
Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota. Electronic address:
Introduction: Goals of left ventricular assist device (LVAD) therapy includes low rates of right ventricular failure (RVF) and favorable survival outcomes. However, conventional metrics often fail to capture its physiologic complexity. We evaluated the prognostic utility of the Active Cardiac Index (ActCI) and Passive Cardiac Index (PasCI)-which reflect cardiac output driven by active RV contractility and passive venous return, respectively.
View Article and Find Full Text PDF